Altacor is creating a leading European specialist ophthalmology company developing and marketing a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The Company's strategy is to build its product base and commercial organisation into major countries in Europe through transactions and partnerships. Altacor's current portfolio, which is marketed by its own sales teams in the UK, comprises prescription and retail ophthalmology products addressing predominantly front-of-the-eye conditions, such as dry eye syndrome and blepharitis.